We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$1.5B
AUM Growth
+$242M
Cap. Flow
+$178M
Cap. Flow %
11.93%
Top 10 Hldgs %
18.61%
Holding
7,153
New
1,586
Increased
2,321
Reduced
1,709
Closed
1,363

Sector Composition

Rank Sector Weight
1 Communication Services 6.61%
2 Healthcare 6.55%
3 Technology 6.45%
4 Consumer Discretionary 4.54%
5 Financials 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRC
3851
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$8K ﹤0.01%
156
-3,489
-96% -$182K
CEQP
3852
DELISTED
Crestwood Equity Partners LP
CEQP
$8K ﹤0.01%
422
-4,435
-91% -$79.8K
LSI
3853
PUT
DELISTED
Life Storage, Inc.
LSI
$8K ﹤0.01%
+57
New +$4.14K
NYMX
3854
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$8K ﹤0.01%
86
-168
-66% -$413
SEAC
3855
PUT
DELISTED
Seachange International Inc
SEAC
$8K ﹤0.01%
+1
New +$74
VIVO
3856
PUT
DELISTED
Meridian Bioscience Inc
VIVO
$8K ﹤0.01%
+132
New +$2.59K
AERI
3857
DELISTED
Aerie Pharmaceuticals
AERI
$8K ﹤0.01%
+511
New +$8.27K
GBT
3858
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
$8K ﹤0.01%
40
+28
+233% +$565
JOBS
3859
PUT
DELISTED
51job Inc
JOBS
$8K ﹤0.01%
79
FOE
3860
CALL
DELISTED
Ferro Corporation
FOE
$8K ﹤0.01%
95
-18
-16% -$239
ARNA
3861
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$8K ﹤0.01%
37
-7
-16% -$125
FPRX
3862
PUT
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$8K ﹤0.01%
38
+17
+81% +$739
HMSY
3863
CALL
DELISTED
HMS Holdings Corp.
HMSY
$8K ﹤0.01%
+144
New +$2.32K
MCEP
3864
DELISTED
Mid-Con Energy Partners, LP
MCEP
$8K ﹤0.01%
+222
New +$12.2K
TLRD
3865
PUT
DELISTED
Tailored Brands, Inc.
TLRD
$8K ﹤0.01%
133
+57
+75% +$842
IBKC
3866
PUT
DELISTED
IBERIABANK Corp
IBKC
$8K ﹤0.01%
68
-50
-42% -$2.9K
AXE
3867
PUT
DELISTED
Anixter International Inc
AXE
$8K ﹤0.01%
+29
New +$1.66K
AVP
3868
CALL
DELISTED
Avon Products, Inc.
AVP
$8K ﹤0.01%
823
+411
+100% +$1.77K
ONCE
3869
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$8K ﹤0.01%
35
+32
+1,067% +$1.37K
NRE
3870
PUT
DELISTED
NorthStar Realty Europe Corp.
NRE
$8K ﹤0.01%
+50
New +$561
AKAO
3871
CALL
DELISTED
Achaogen Inc
AKAO
$8K ﹤0.01%
+35
New +$122
ITG
3872
PUT
DELISTED
Investment Technology Group Inc
ITG
$8K ﹤0.01%
+10
New +$188
VXZ
3873
PUT
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
$8K ﹤0.01%
44
+42
+2,100% +$1.85K
LKM
3874
PUT
DELISTED
Link Motion Inc.
LKM
$8K ﹤0.01%
127
-660
-84% -$2.91K
WIN
3875
PUT
DELISTED
Windstream Holdings Inc
WIN
$8K ﹤0.01%
40
-99
-71% -$4.22K

Similar funds

Simplex Trading's Q2 2016 Portfolio in Review

As of Q2 2016, Simplex Trading held 7,153 positions worth $1.5B, up 19% from $1.25B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Simplex Trading deployed $178M of net new capital in Q2 2016, opening 1,586 new positions and adding to 2,321 existing holdings. Its largest new stake was Biogen: 56,467 shares worth $13.7M.

By sector, the portfolio is most concentrated in Communication Services at 6.6% of assets, down from 6.9% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Broadcom, an estimated $36.7M trimmed.

  • Simplex Trading's largest Q2 2016 buy was Biogen: 56,467 shares worth $13.7M.
  • Simplex Trading added most to LinkedIn Corporation in Q2 2016, an estimated $21.4M increase.
  • Simplex Trading's biggest Q2 2016 reduction was Broadcom, cutting an estimated $36.7M.
  • Simplex Trading fully exited Alphabet (Google) Class C in Q2 2016, selling an estimated $20.1M.
  • Simplex Trading's ten largest holdings make up 19% of its $1.5B portfolio in Q2 2016.
  • Simplex Trading opened 1,586 new positions and closed 1,363 in Q2 2016.
  • Simplex Trading's portfolio value rose 19% quarter-over-quarter to $1.5B.

Based on Simplex Trading's 13F filing for Q2 2016, filed 18 Jul 2016.